1-5 of 5
Francois Lokiec
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A118: PIKHER2: A phase Ib study evaluating oral BKM120 in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer

Anthony Gonçalves, Mathilde Guerin, Nicolas Isambert, Mario Campone, Keyvan Resai, Aurélie Autret, Jihane Pakradouni, Alexie Robert, Magali Provansal, Emmanuelle Charafe-Jauffret, Renaud Sabatier, Alice Hervieu, Jean-Marc Extra, Patrice Viens, François Lokiec, Jean-Marie Boher
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A118.
https://doi.org/10.1158/1535-7163.TARG-15-A118
Published: 01 December 2015
View article titled, Abstract A118: PIKHER2: A phase Ib study evaluating oral BKM120 in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer
Journal Articles

Abstract A72: A first-in-man Phase I study of the galectin-1 (gal-1) inhibitor OTX008 given subcutaneously as a single agent to patients with advanced solid tumors.

Jean-Pierre Delord, Ahmad Awada, Eric Raymond, François Lokiec, Patrice Herait, Keyvan Rezai, Nicolas Lachaux, Gabriel A. Rabinovich, Carlos Gomez-Roca, Philippe Aftimos, Sandrine Faivre, Juan Carlos Stupirski
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A72.
https://doi.org/10.1158/1535-7163.TARG-13-A72
Published: 01 November 2013
View article titled, Abstract A72: A first-in-man Phase I study of the galectin-1 (gal-1) inhibitor OTX008 given subcutaneously as a single agent to patients with advanced solid tumors.
Journal Articles

Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells

Maria Serova, Aïda Ghoul, Karim A. Benhadji, Sandrine Faivre, Christophe Le Tourneau, Esteban Cvitkovic, Francois Lokiec, Janet Lord, Steven M. Ogbourne, Fabien Calvo, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 915–922.
https://doi.org/10.1158/1535-7163.MCT-07-2060
Published: 15 April 2008
View article titled, Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells
Open the PDF for Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells in another window
Journal Articles

Resistance to PKCδ activators yield an increased endothelin-1-mediated invasive phenotype in human cancer cells

Aida Ghoul, Maria Serova, Ivan Bieche, Nasredine Aissat, Christophe Le Tourneau, Michel Vidaud, Francois Lokiec, Eric Raymond, Sandrine Faivre
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A183.
Published: 01 November 2007
View article titled, Resistance to PKCδ activators yield an increased endothelin-1-mediated invasive phenotype in human cancer cells
Journal Articles

Molecular and cellular effects of AP5346, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines

Maria Serova, Nasredine Aissat, Aida Ghoul, Keyvan Rezai, Ivan Bieche, Michel Vidaud, Sergio Szyldergemajn, David Nowotnik, Francois Lokiec, Sandrine Faivre, Eric Raymond
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C105.
Published: 01 November 2007
View article titled, Molecular and cellular effects of AP5346, a novel DACH-platinum linked polymer-compound, compared to oxaliplatin and cisplatin in a panel of human cancer cell lines